Purdue Pharma LP - Company Profile
Powered by 
All the sales intelligence you need on Purdue Pharma LP in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Purdue Pharma LP fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Purdue Pharma LP.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Purdue Pharma LP (Purdue) develops pharmacologic therapies for the treatment and management of pain.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Purdue is actively engaged in several R&D initiatives, focusing primarily on opioid overdose reversal. The company is involved in clinical trials to assess the safety and efficacy of investigational medicines, including Nalmefene HCl Injection, for opioid overdose treatment. Purdue Pharma LP also supports investigator-initiated research projects and collaborative research initiatives to better understand opioid overdose reversal and inform future research to advance patient care. The company is committed to providing expanded access to investigational medicines for patients who meet specific criteria and are ineligible for clinical trials. The R&D unit of Purdue Pharma LP is the Medical Affairs department, which is responsible for pursuing collaborative research to enhance understanding of opioid overdose reversal and to inform future research efforts. This unit manages the company's R&D activities, including funding investigator-initiated research projects and evaluating research proposals.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer